Results 121 to 130 of about 49,741 (289)

Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours

Andrology, EarlyView.
Abstract Background Testicular germ cell tumours (TGCTs) are amongst the most common malignancies in young men, and their incidence is increasing worldwide. Tissue heterogeneity hampers efforts to understand how TGCT precursors (termed germ cell neoplasia in situ; GCNIS) emerge and progress, restricting elucidation of new strategies for diagnosis and ...
Sarah C. Moody, Daniela Fietz, Benedict Nathaniel, Mark Frydenberg, Ben Tran, Hans‐Christian Schuppe, Kate L. Loveland   +6 more
wiley   +1 more source

Alpha-fetoprotein and the prenatal detection of neural tube defects. [PDF]

, 1979
Aubrey Milunsky
openalex   +1 more source

Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma

Alimentary Pharmacology &Therapeutics, EarlyView.
Serum metabolites may guide post‐treatment risk stratification for HCC recurrence. ABSTRACT Patients with hepatocellular carcinoma (HCC) often experience recurrence after curative therapies, underscoring a need for risk stratification models. We validated 6 and 13‐metabolite signatures in patients who achieved complete response following surgical ...
Ashwini Arvind, Hiroaki Kanzaki, Fouzia Ahmed, Naoto Fujiwara, Yujin Hoshida, Amit G. Singal   +5 more
wiley   +1 more source

Letter: Serum alpha-fetoprotein in cystic fibrosis. [PDF]

, 1975
G Knopple, H. W. Rotthauwe, Fritz Lėhmann   +2 more
openalex   +1 more source

Antimicrobial prescribing guidelines for horses in Australia

Australian Veterinary Journal, EarlyView.
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt, K Thomas, S Page, J Norris, G Browning, C El Hage, A Stewart, J Gilkerson, G Muscatello, D Verwilghen, G van Galen, J Bauquier, R Cuming, B Reynolds, C Whittaker, E Wilkes, J Clulow, C Burden, L Begg   +18 more
wiley   +1 more source

Costs and benefits of serum alpha-fetoprotein screening. [PDF]

, 1978
Andrew Read
openalex   +1 more source

Hereditary persistence of alpha-fetoprotein

The Netherlands Journal of Medicine, 2011
Contains fulltext : 95953.pdf (Publisher’s version ) (Open Access)
Deuren, M. van, Verhagen, M., Weemaes, C.M.R.   +2 more
openaire   +3 more sources

Assessment of new prognostic risk models for recurrence in patients with clinical stage I seminoma

BJU International, EarlyView.
Objectives To evaluate two new prognostic risk models aimed at improving clinical decision‐making in patients with clinical stage (cS) I seminomatous testicular germ cell tumours (GCTs), 5%–30% of whom experience recurrence during surveillance after orchiectomy and may benefit from adjuvant therapy.
Angelina Strauch, Justine Schoch, Martin Hellmich, Hans Schmelz, Tim Nestler   +4 more
wiley   +1 more source

Serum alpha-fetoprotein levels in neonatal cholestasis

The Turkish Journal of Pediatrics, 2013
Alpha-fetoprotein (AFP) is used as a tumor marker for hepatocellular carcinoma, hepatoblastoma and germ cell tumors. It may also be elevated in infants with some hepatobiliary disorders.
Hülya Demir, Gülin Hızal, Nuray Uslu Kızılkan, Figen Gürakan, Beril Talim, Turgay Coşkun, Gülsev Kale, Aysel Yüce   +7 more
doaj  

Letter: Raised alpha-fetoprotein levels and congenital defect. [PDF]

, 1976
N. C. Nevin, W. J. Thompson, George T. Roberts   +2 more
openalex   +1 more source